Effects of bacillus calmette-guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer
Open Access
- 15 January 1992
- Vol. 69 (2) , 537-545
- https://doi.org/10.1002/1097-0142(19920115)69:2<537::aid-cncr2820690242>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Urinary interleukins in patients receiving intravesical bacillus calmette-guerin therapy for superficial bladder cancerCancer, 1989
- Changes of the mucosal architecture and of urine cytology during BCG treatmentWorld Journal of Urology, 1988
- Experience with Bacillus Calmette-Guérin in Patients with Superficial Bladder TumorsEuropean Urology, 1987
- Detection of Interleukin 2 in the Urine of Patients with Superficial Bladder Tumors after Treatment with Intravesical BCGJournal of Urology, 1986
- Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: Lack of a role of natural killer cellsClinical Immunology and Immunopathology, 1986
- Histopathology of BCG and thiotepa treated bladdersUrological Research, 1986
- Prognostic Value of Purified Protein Derivative Skin Test and Granuloma Formation in Patients Treated with Intravesical Bacillus Calmette-GuerinJournal of Urology, 1986
- BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responsesCancer, 1981
- Immune surveillance revisitedNature, 1977
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976